EGFR and glioblastoma: One hypothesis is that such mutation leads to TERT overexpression and facilitates telomerase reactivation, which overcomes replicative senescence.[160] Interestingly, EGFR mutations were observed to highly appear in GBM with TERT mutations.[60] Several preclinical studies are developing gene therapies that target TERT and its downstream pathways.